ELBA – European Liquid Biopsies Academy project – Towards widespread clinical application of blood-based diagnostic tools
The European Liquid Biopsy Academy (ELBA) project is an Innovative Training Network (ITN), funded under the European Commission's Marie Sklodowska-Curie Programme, aiming to move the promising technology of liquid biopsies out of its infancy and bring it to the clinic with a further focus on Non-Small Cell Lung Cancer (NSCLC) early diagnosis. Liquid biopsies offer a minimally invasive, safe, and sensitive alternative or complementary approach for tissue biopsies, which can be a game-changer in cancer management.
- Researcher:michael hackenberg
- Group: TEC16-ADVANCED THERAPIES: DIFFERENCE-REGENATION-CANCER
- Centre: University of Grenada
- Role in the project: Project Participants
- Duration: 2018-2022
Project website: https://elbaproject.eu/